![]() VIVUS VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 1991 | Founding Date 1935 | Founding Date 1985 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Campbell, US HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 594% increase | Employees 27,764 | Employees 9,067 |
Valuation ($) | Valuation ($) 8.3 m | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $69.8m (FY, 2019) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods $15.7m (FY, 2019) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit $54.1m (FY, 2019) | Gross profit ₹195b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income ($31.5m) (FY, 2019) | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) |

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company